Items where authors include "Selby, P."

Article

Collinson, F. orcid.org/0000-0001-6964-6406, Royle, K.-L. orcid.org/0000-0003-0225-1199, Swain, J. orcid.org/0000-0003-2729-3029 et al. (28 more authors) (2024) Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. Health Technology Assessment, 28 (45). ISSN 1366-5278

Brown, J.E. orcid.org/0000-0003-4960-3032, Royle, K.-L., Gregory, W. et al. (96 more authors) (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. The Lancet Oncology, 24 (3). pp. 213-227. ISSN 1470-2045

Brown, J.E., Handforth, C., Compston, J.E. et al. (13 more authors) (2020) Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group. Journal of Bone Oncology, 25. 100311. ISSN 2212-1374

Davis, S., Simpson, E., Hamilton, J. et al. (6 more authors) (2020) Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Health Technology Assessment, 24 (29). ISSN 1366-5278

Simpson, E. orcid.org/0000-0001-7353-5979, Martyn-St James, M., Hamilton, J. et al. (4 more authors) (2020) Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures : a systematic review and network meta-analysis. Bone, 130. ISSN 8756-3282

Banks, I., Weller, D., Ungan, M. et al. (16 more authors) (2019) ECCO essential requirements for quality cancer care : primary care. Critical Reviews in Oncology/Hematology, 142. pp. 187-199. ISSN 1040-8428

Downing, A., Wright, P., Hounsome, L. et al. (23 more authors) (2019) Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncology, 20 (3). pp. 436-447. ISSN 1470-2045

Donnelly, D.W., Donnelly, C., Kearney, T. et al. (26 more authors) (2018) Urinary, bowel and sexual health in older men from Northern Ireland. BJU International, 122 (5). pp. 845-857. ISSN 1464-4096

Compston, J., Cooper, A., Cooper, C. et al. (13 more authors) (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 12 (1). p. 43. ISSN 1862-3522

Downing, A., Wright, P., Wagland, R. et al. (24 more authors) (2016) Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study. BMJ Open, 6 (12). ARTN e0135.

Davis, S., Martyn-St James, M. orcid.org/0000-0002-4679-7831, Sanderson, J. et al. (10 more authors) (2016) Corrigendum: A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20 (78). pp. 407-424. ISSN 1366-5278

Davis, S., Martyn-St James, M. orcid.org/0000-0002-4679-7831, Sanderson, J. et al. (10 more authors) (2016) A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures. Health Technology Assessment, 20 (78). pp. 1-406. ISSN 1366-5278

Walsh, J. orcid.org/0000-0002-7122-2650, Gittoes, N. and Selby, P. (2016) SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute hypercalcaemia in adult patients. Endocrine Connections, 5 (5). G9-G11. ISSN 2049-3614

Sanderson, J. orcid.org/0000-0003-3326-9842, Martyn-St James, M., Stevens, J. et al. (6 more authors) (2016) Clinical effectiveness of bisphosphonates for the prevention of fragility fractures: A systematic review and network meta-analysis. Bone, 89. pp. 52-58. ISSN 1873-2763

Baird, R., Banks, I., Cameron, D. et al. (53 more authors) (2016) An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patients. Ecancermedicalscience, 10. p. 608.